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Abstract
The effects of the organic calcium channel blocker verapamil and the L-receptor blocker propranolol on dipole (Pd) and
surface (Ps) potentials of bilayer lipid membranes were studied. The boundary potentials (Pb = Pd+Ps) of black lipid
membranes, monitored by conductance measurements in the presence of nonactin and by capacitive current measurements
were compared with Ps calculated from the electrophoretic mobility of lipid vesicles. It was shown that the increase of
boundary potential, induced by the adsorption of the positively charged propranolol, was caused solely by an increase in
surface potential. Although Ps also increases due to the adsorption of verapamil, Pb diminishes. A sharp decrease of the
dipole potential was shown to be responsible for this effect. From Langmuir adsorption isotherm the dissociation constant
Kd of verapamil was estimated. The uncharged form of verapamil (Kd = (0.061 þ 0.01) mM at pH 10.5) has a tenfold higher
affinity to a neutral bilayer membrane than the positively charged form. The alteration of membrane dipole potential due to
verapamil adsorption may have important implications for both membrane translocation and partitioning of small or
hydrophobic ions and charged groups of membrane proteins. ß 1998 Elsevier Science B.V. All rights reserved.
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1. Introduction
Verapamil (Fig. 1) is a calcium channel blocker
and a well-established drug in the treatment of angi-
na pectoris, cardiac arrhythmia, cardiomyopathies,
hypertension [1] and migraine [2]. It is believed that
the main site of its highly speci¢c action is the volt-
age-dependent calcium channel in two tissues: the
cardiac cell membrane and vascular smooth muscle
[1,3]. Reducing intracellular free calcium concentra-
tion, verapamil causes coronary and peripheral vaso-
dilation and depresses myocardial contractility and
electrical activity in the atrioventricular and sino-
atrial nodes [1]. In the last years the importance of
verapamil as multidrug resistance (MDR) modulator
is increased [4]. It is assumed that the mechanism of
MDR reversal is based on inhibition of P-glycopro-
tein mediated drug e¥ux by binding at the enzyme at
a di¡erent binding site or direct competition for drug
e¥ux. Alteration of active as well as passive trans-
port of an anti-cancer drug in the presence of
verapamil was found [5^7]. Propranolol (Fig. 1) is
a L-receptor blocker and is used in heart disease
treatment similar to verapamil.
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The exact molecular mechanism whereby these two
agents work is still unknown; the studies have fo-
cused on the characterization of binding sites [8] or
on the e¡ect on active anti-cancer drug e¥ux (for
verapamil). The e¡ects of these drugs on intrinsic
membrane potentials were not investigated yet.
Both substances are also frequently used in experi-
ments in vitro as selective channel or receptor inhib-
itors. However, it was suggested earlier [9] that they
are able to alter the potential distribution across bio-
logical membranes.
The existing model of a potential pro¢le across the
water-membrane boundary supposes the considera-
tion of at least two parts of boundary potential Pb.
The biological signi¢cance and the origin of the sur-
face potential (Ps) is well known [10]. Lipid bilayers
possess moreover a large membrane potential, posi-
tive inside, the so-called dipole potential (Pd). It was
found to be approx. 280 mV in phosphatidylcholine
membranes [11,12]. This component of the total
membrane potential arises from dipoles located, for
the most part, in the transition region between the
aqueous phase and the hydrocarbon-like interior of
the membrane [13,14]. Pd seems, however, to play a
very important role because it strongly a¡ects bind-
ing and transport of ions [15,16]. Consequently, cau-
tion is required when indicator substances are used
as probes of electrical events in cells or model mem-
brane systems. Contribution of the dyes themselves
to the magnitude of membrane potentials must be
excluded [17,18].
The aim of this study was to investigate the
changes of the potential distribution across the mem-
brane boundary induced by verapamil or proprano-
lol with special attention to possible alterations of
the dipole potential. The results of three di¡erent
methods (membrane capacitance minimization tech-
nique, conductance measurements in the presence of
nonactin and j-potential measurements) were crit-
ically compared. The ¢rst and second methods allow
to determine the drop vPb of the potential di¡erence
between the adsorption surface and some point in
the bulk. With the last method only the potential
at the surface of shear, the so-called zeta-potential,
j, is measured. Our results indicate that the adsorp-
tion plane of verapamil is localized deeper than that
of propranolol.
2. Materials and methods
2.1. Chemicals
Diphytanoylphosphatidylcholine (DPhPC) and di-
phytanoylphosphatidylserine (DPhPS) were obtained
from Avanti Polars Lipids (Alabaster, AL, USA).
Lipids were stored at 370‡C and used without fur-
ther treatment. For the preparation of bu¡er solu-
tions Tris (Fluka, Buchs, Switzerland), MES (4-mor-
pholineethanesulfonic acid; Boehringer, Mannheim,
Germany), CAPSO (3-[cyclohexylamino]-2-hydroxy-
1-propanesulfonic acid; Sigma, St. Louis, MO) and
KCl (Fluka, Buchs, Switzerland) were used. Verapa-
mil hydrochloride and propranolol hydrochloride
were obtained from Fluka (Buchs, Switzerland).
2.2. Formation of bilayer lipid membranes
The bilayer lipid membranes (BLMs) were formed
by the conventional Mueller-Rudin technique in
holes, 0.5^1 mm in diameter, of a diaphragm of a
polytetra£uoroethylene (PTFE) chamber [19]. The
membrane-forming solution contained 20 mg
DPhPC or DPhPS, dissolved in 1 ml of n-decane
(Merck, Darmstadt, Germany). The bilayers sur-
rounding solution contained typically 20 mM Tris,
20 mM MES, 20 mM CAPSO and 10 or 100 mM
KCl. It was agitated by magnetic bars. The experi-
ments were carried out at room temperature (23^
25‡C).
Stock solutions of verapamil or propranolol were
added bi- (conductance measurements) or unilater-
ally (capacitance minimization technique).
2.3. Preparations of liposomes
The procedures for preparing phospholipid lipo-
somes were similar to those described in the litera-
ture [20]. DPhPC or DPhPS was dissolved in chloro-
form. After removing the solvent by evaporation, a
thin ¢lm of a lipid on the wall of a round bottom
£ask was formed. An appropriate volume of the
bu¡er (20 mM Tris, 20 mM MES, 20 mM CAPSO
and 100 mM KCl) was then added into the £ask and
the solution was vortexed for 3 min. The resulting
multilamellar vesicles were sonicated in order to re-
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duce vesicle dimensions. The diameter of liposomes,
a, was determined from light scattering, using Coult-
er DELSA 440. Typically, it was equal to 300 nm.
2.4. Conductance measurements
Current-voltage relationships were measured with
a current ampli¢er (Model 428, Keithley Instru-
ments, Cleveland, OH, USA) using the built-in volt-
age source. The e¡ect of verapamil and propranolol
on the nonactin-induced conductance was used to
study their adsorption behavior at di¡erent pH val-
ues [21]. The change of Pb was deduced from the
relation of the initial conductance G0 and the con-
ductance G in presence of substances studied [22].
G
G0
 exp zFPb
RT
 
1
2.5. Monitoring of the boundary potential drop
between the lipid layers using the inner ¢eld
compensation method (IFC)
The method is based on the dependence of the
capacitance on the inner membrane ¢eld, i.e., the
electric potential gradient within the membrane,
and allows to measure the potential di¡erence be-
tween the boundaries of a bilayer [23^26]. Membrane
capacitive current contains a signal harmonic to the
applied fundamental frequency (418 Hz) which van-
ishes if a DC signal coinciding with the boundary
potential di¡erence is transferred to the reference
electrodes additionally to the AC signal. The magni-
tude of the DC signal Vc is given directly by
V c  3vPs  vPd 2
where vPs is the di¡erence in surface potentials be-
tween the two bilayer surfaces and vPd is the dipole
potential di¡erence between the two monolayers.
Both drugs studied are weak bases with pKa values
between 8 and 9. It was shown previously that the
permeation of weak acids and bases is accompanied
by the formation of a transmembrane pH gradient
[27]. Passing in their uncharged form across the
membrane, verapamil and propranolol dissociate at
one side of the membrane and associate with a pro-
ton at the other side (Fig. 2). A local pH shift in the
unstirred layers is produced [28]. Diminishing the
steady state concentration of the neutral drug, it
counteracts the di¡usion. In our experiments, we
have preestablished a large, similar directed pH dif-
ference across the membrane to ensure that a negli-
gible transmembrane di¡usion occurs [29]. In this
case, the measured potential di¡erence is identical
with the boundary potential drop of one monolayer
due to the adsorption of substances on the lipid-solu-
tion boundary.
2.6. j-Potential measurements
Measurements of the electrophoretic mobility of
Fig. 1. Chemical structure of the studied drugs.
Fig. 2. Membrane transport of verapamil and propranolol.
Only the neutral form of both substances, T0, is able to di¡use
across the bilayer.
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liposomes were carried out with the Coulter DELSA
440 (Langley Ford Instruments, Coulter Electronics
of New England). The velocity of liposome move-
ment in an electrical ¢eld was deduced from the
Doppler shift of a scattered laser beam.
In order to determine the j-potential from the elec-
trophoretic mobility we have used Eq. 3, derived by
Smoluchowsky [30]:
j  RU
OO0
3
where U is the electrophoretic mobility of liposomes,
R is the viscosity of the solution and O is the dielec-
trical constant of the medium. This equation is ap-
plicable for values of UaE1, where U is the Debye
constant (Eq. 6) and a is the diameter of liposomes
[31]. Additionally, we have made control experiments
measuring the j-potential of PC/PS liposomes at dif-
ferent concentrations of the electrolyte as described
in [32]. Our experimental data were in good agree-
ment with data shown therein.
3. Results
3.1. Measurements of the surface potential
The binding of verapamil and propranolol to bi-
layer membranes was monitored in terms of j and
boundary Pb potential changes. j was measured as a
function of the concentration of verapamil and pro-
pranolol, pH, the lipid composition and the ionic
strength of the bu¡er solution. It was shown that
adsorbing to the neutral membrane both verapamil
(Fig. 3A) and propranolol (Fig. 3B) increase the
j-potential. Both drugs show an enhanced binding
in the presence of negatively charged phospholipids
such as DPhPS (Fig. 4, R), indicating that electro-
static interactions are involved.
From measured j-potentials Ps was calculated, ac-
cording to Eqs. 4^6 [33]:
P  2kT
ze
ln
1 K exp3UN
13 K exp3UN 4
where
K  expzePs=2kT 31
expzePs=2kT   1 5
and
U 

2e2z2CNA
OO0kT
s
; 6
where C, 1/U, k, N are, respectively, the concentration
of the electrolyte, the Debye length, the Boltzmann
constant and the distance of the shear plane from the
surface; e, NA, z, T, O have their usual meanings.
Assuming N= 0.2 nm [31], we obtain P= j.
The Gouy-Chapman theory of the di¡use double
layer predicts that the potential due to charge ad-
sorption at the surface of a membrane Ps is related
to the total concentration of a monovalent electro-
lyte in the bulk solution, C :
Fig. 3. Dependence of j-potential on drug concentration and
ionic strength of bu¡er solutions for verapamil (A) and pro-
pranolol (B). Liposomes were made from DPhPC, pH of bu¡er
solution was 6.5.
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ca  c0
8OO0RTC
p  sinh Pse
2kT
7
where (ca+c0) is surface charge density due to the
adsorption of charged substances and the initial
charge of the lipid. As expected, a decrease of Ps in
the presence of verapamil or propranolol with an
increase of ionic strength of bu¡er solution was
found (Fig. 3). To relate the aqueous concentration,
c0, at the surface of the membrane to the bulk aque-
ous concentration, c, we have used the Boltzmann
equation (Eq. 8) [34] assuming z = +1 for verapamil
and propranolol :
c0  c W exp3zFPsRT 8
Since the membranes (c0 = 0) were initially neutral,
the surface charge was produced by the adsorption
of cations cs. Consequently, Ps was not constant dur-
ing the titration and it follows that the dissociation
constant K was not constant for a given ionic con-
centration.
3.2. Measurements of the dipole potential
The measurements of boundary potential altera-
tion due to the adsorption of verapamil and propran-
olol were carried out with the IFC method. Obtained
data show that vPb decreases after the addition of
verapamil (Fig. 5A). With respect to the increase of
the surface potential obtained, we have made the conclusion that the decrease of the boundary poten-
tial occurs due to the strong decrease of the dipole
potential. On the contrary, the increase of the boun-
dary potential induced by propranolol (Fig. 5B) is
similar to the surface potential change.
From the knowledge that verapamil alters the di-
pole potential, some further predictions can be made.
It is already well established that the membrane di-
pole potential is responsible for di¡erences in perme-
ability of hydrophobic ions [16], charged carriers,
some potential sensitive dyes, charged spin label
probes [35] and non-electrogenic carriers [36]. Vera-
pamil was expected to increase the permeability for
the nonactin-K complex, because a decrease of the
positive inner membrane potential is accompanied by
an increase of the permeability for positively charged
hydrophobic ions [37,38]. The adsorption of pro-
pranolol, on the contrary, should increase the energy
Fig. 4. Dependence of j-potential on concentration of verapa-
mil and on lipid composition. The bu¡er solution contained
100 mM KCl, pH 6.5.
Fig. 5. Boundary potential alteration after the addition of vera-
pamil (A) or propranolol (B) measured with the IFC method.
BLMs were made from DPhPC (20 mg/ml).
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barrier and consequently diminish the permeability
for the positive charged carrier. To prove our as-
sumption, we have monitored changes of the con-
ductance of a BLM doped with nonactin. In fact,
propranolol decreases the permeability for nonactin,
whereas it is increased by verapamil (Fig. 6).
Based on the experimental values for the surface
and the boundary potentials, calculated using Eq. 1,
the dipole potential was estimated according to Eq.
9:
vPd  vPb3vPs 9
The use of this equation is justi¢ed by the assump-
tion that the amount of drugs bound to liposomes is
negligible in comparison to the total amount of
drugs in solution. We have checked the concentra-
tion of verapamil in bu¡er solutions with a spectro-
photometer [5] and concluded that it was not altered
by the addition of lipid (data not shown). In Fig. 7
both substances are compared. It can be seen that
the boundary potential vPb induced by verapamil
(b,a) di¡ers from the surface potential vPs. For pro-
pranolol they are rather similar (F,E).
The changes of the dipole potential of lipid bi-
layers due to the adsorption of verapamil saturate
with increasing concentrations of the compound.
The experimental data are well described by a Lang-
muir adsorption isotherm. Fig. 8 shows this type of
plot for verapamil. Quantitatively similar adsorption
characteristics were found for phloretin [22,39]. It
was shown that the adsorption isotherm can be re-
written in terms of dipole potential changes [40]:
Pd  Pmaxd
c
Kd  c; 10
where c is the drug concentration in the aqueous
phases. The maximal change of the dipole potential,
Pmaxd , is reached when all binding places are occupied.
From Eq. 10 the dissociation constant Kd can be
estimated.
Because 99.9% of verapamil exists in its neutral
form at pH 10.5 and in its positively charged form
at pH 6.4 (Eq. 11)
Fig. 7. Comparison of the boundary potential (b,F) deduced
from the membrane conductance in the presence of nonactin
and the surface potential (a,E). The latter was calculated from
j-potential measurements at di¡erent concentrations of verapa-
mil (b,a) and propranolol (F,E). The bu¡er solution contained
100 mM KCl. pH was 6.5.
Fig. 6. Typical record of the e¡ect of verapamil and proprano-
lol on the transmembrane current.
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T
TH  10
pH3pK 11
the binding constant was determined for each form
separately. Kd and Ps at pH 10.5 can be easily esti-
mated from the Langmuir isotherm, because vPs = 0.
They equal (0.061 þ 0.01) mM and (122 þ 5) mV re-
spectively (Fig. 8). At pH 6.4 Kd is a function of vPs.
Knowing vPmaxd and vPs, we determined Kd for each
verapamil concentration (Eqs. 8,10). The calculated
values of Kd varied in the range from 0.5 to 1 mM.
4. Discussion
Verapamil and propranolol are positively charged
at physiological pH and induce, as expected, an in-
crease in the surface potential of the BLM. Their
contribution to vPs is rather similar.
On the contrary, vPb found after verapamil and
propranolol adsorption were opposite in sign (Figs.
5 and 6). The boundary potential drop induced by
propranolol is based entirely on the change of the
surface potential due to the adsorption of the posi-
tively charged substance. In the case of verapamil,
the comparison of vPb and Ps shows that vPb, ob-
tained by capacitive current and conductance meas-
urements, are signi¢cantly smaller than the values of
Ps, calculated from j-potential values (Figs. 7 and 9).
From these di¡erences it is obvious that the boun-
dary potential drop is based not only on the change
of the surface potential positive in sign but also on a
simultaneous large dipole potential drop, negative in
sign (Fig. 9).
Supposing that at pH 6.4 verapamil is positively
charged and it is uncharged at pH 10.5, we were able
to compare the adsorption constants for both forms.
The a⁄nity of the neutral form of verapamil is ten-
fold higher. This result seems to be reasonable, be-
cause repulsive ion-ion interactions take place only at
the lower pH.
The dissociation constant of the uncharged vera-
pamil was calculated from Langmuir isotherms (Fig.
8), because, both experimentally and theoretically,
the dipole-dipole interactions are so weak that they
have only a minor e¡ect on the adsorption [22]. On
monolayers Cseh and Benz have shown recently that
alterations of the intrinsic membrane potential intro-
duced by phloretin have an in£uence on the adsorp-
tion of subsequent molecules with dipole moments
[41]. The authors have also seen a minor impact of
electrostatics on the adsorption on bilayers [41] that,
however, has not been observed before [22,39,40,42].
There is no complete understanding why the adsorp-
tion parameters are di¡erent between monolayers
and bilayers [41]. The most obvious di¡erence is
the orientation of the adsorbing dipole. In bilayers
the dipole moment of phloretin was shown to make
an angle to the membrane surface [12] that is di¡er-
ent from 90‡ usually assumed for monolayers [41].
Fig. 9. Changes of the total potential pro¢le for the interactions
of charged molecules with lipid bilayers due to the adsorption
of verapamil (A) and propranolol (B). Ps, Pd, Pb are surface, di-
pole and boundary potentials respectively; Pvs , P
v
d, P
v
b and P
p
s ,
Ppd, P
p
b are the same potentials after addition of verapamil or
propranolol.
Fig. 8. Dependence of membrane dipole potential on verapamil
concentration at pH 10.5 of the bu¡er solution. The bu¡er
solution contained 100 mM KCl. BLM was made from
DPhPC.
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Moreover, the large deviations in the dipole potential
measured for monolayers and bilayers [10] may also
in£uence, at least in part, the adsorption behavior.
With respect to these considerations, it is more
straightforward to evaluate drug-induced dipole po-
tential changes from the nonactin mediated bilayer
conductance than from boundary potential changes
of lipid monolayers.
To separate potential changes from drug induced
mobility changes within the membrane, an indicator
free method for boundary potential measurements
was also used. Because the same results have been
obtained with the inner ¢eld compensation method
and with conductance measurements, an in£uence of
the drugs on the membrane £uidity is extremely un-
likely. Additionally, Shi and Tien [9] have shown that
the verapamil concentration required to produce the
detectable £uidizing e¡ect is tenfold (0.01 M) the
highest concentration used in our experiments.
Our ¢ndings might have important implications
for drug and ion transport studies in intact cells.
Conformational changes of ion channels or receptors
that involve the movement of charges or dipoles
across the membrane interface could be strongly in-
£uenced by the dipole potential [43]. Rokitskaya et
al. have found that phloretin, known to lower the
dipole potential, a¡ects the process of channel disso-
ciation [44]. Fluorescent potential-sensitive dyes of
the RH series, shown to increase the dipole potential
[18], are supposed to a¡ect the electrogenic transport
performed by the sodium pump. Extrapolated to
clinically relevant verapamil concentrations (WM
range), the observed changes of the dipole potential
are rather small. However, at essentially higher con-
centrations (mM range) verapamil is widely used in
patch-clamp experiments (e.g. [45]). With respect to
our results, it cannot be excluded that artifacts are
introduced due to the non-speci¢c alteration of mem-
brane characteristics.
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